
Sign up to save your podcasts
Or


Dr. Raymond Tjandrawinata, executive director at Dexa Laboratories of Biomolecular Sciences (DLBS), talks about collective conscience, co-evolving with pathogens, and the first monoclonal antibody therapy in Indonesia—a breakthrough treatment for patients with preexisting comorbidities and elderlies.
In collaboration with PT Dexa Medica.
By Endgame Podcast4.4
1414 ratings
Dr. Raymond Tjandrawinata, executive director at Dexa Laboratories of Biomolecular Sciences (DLBS), talks about collective conscience, co-evolving with pathogens, and the first monoclonal antibody therapy in Indonesia—a breakthrough treatment for patients with preexisting comorbidities and elderlies.
In collaboration with PT Dexa Medica.

4,178 Listeners

1,175 Listeners

1,056 Listeners

882 Listeners

1,108 Listeners

348 Listeners

18 Listeners

795 Listeners

693 Listeners

1,395 Listeners

1 Listeners

183 Listeners

2 Listeners

23 Listeners

149 Listeners